Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 0 | 0 | 0 | 0 |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | 4.3M | 2.6M | 1.6M | 2.1M |
Selling general and admin | 1.7M | 1.9M | 1.1M | 1.6M |
Other operating expenses | — | — | — | — |
Operating income | -6.0M | -4.4M | -2.7M | -3.7M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 0 | 0 | 0 | 76.8K |
Other income expense | 5.8M | 13.7M | 90.0K | 118.3K |
Pretax income | -238.2K | 9.3M | -2.6M | -3.6M |
Tax provision | — | — | — | — |
Net income | -238.2K | 9.3M | -2.6M | -3.6M |
Basic EPS | — | 0.3 | -0.1 | -0.2 |
Diluted EPS | — | 0.3 | -0.1 | -0.2 |
Basic average shares | — | 30.0M | 19.8M | 19.5M |
Diluted average shares | — | 30.1M | 19.8M | 19.5M |
EBITDA | -5.8M | -7.7M | -2.7M | -3.5M |
Net income from continuing op. | -238.2K | 9.3M | -2.6M | -3.6M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |